Apr 14, 2024, 15:19
Eddie Cliff: Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs
Eddie Cliff, Research Fellow at
“Delighted to present our work at AACR24 today, led by Ian Liu, on oncology accelerated approvals, simultaneously published at JAMA.
Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs.”
Read further.
Source: Eddie Cliff/X